NARP syndrome in a patient harbouring an insertion in the <i>MT-ATP6</i> gene that results in a truncated protein

Ester López‐Gallardo, A Solano, María Dolores Herrero-Martín, Íñigo Martínez‐Romero, M D Castano-Perez, Antoni L. Andreu, Antonio Herrera, M.J. López-Pérez, Eduardo Ruiz‐Pesini, Julio Montoya

Journal of Medical Genetics · 2009 · 53 citations · 18 references

Concepts

Abstract

BACKGROUND: Neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) syndrome have been associated to m.8993T>G/C mutations in the subunit 6 of the ATP synthase (p.MT-ATP6). METHODS: We have performed a mutational screening of the mitochondrial DNA gene encoding for this protein in 62 patients with the disease, that do not carry any of the common mutations described to date. RESULTS: We report clinical and molecular data in one patient who harbours a de novo insertion in the MT-ATP6 gene that results in a truncated subunit. The mutation was heteroplasmic (85%) in muscle DNA and the BN-PAGE analysis showed a clear decrease in the amount of ATP synthase. CONCLUSION: Molecular analysis of NARP patients cannot be limited to the search of the m.8993T>G/C and either the ATP6 or the whole mtDNA should be sequenced.

References

18